Feline Hyperthyroidism: Welfare Outcomes of Radioiodine Treatment

Hyperthyroidism is the most common endocrine disorder in older cats, and radioiodine therapy offers a curative treatment with excellent welfare outcomes compared to lifelong medication.

Key Facts

Hyperthyroidism affects approximately 10% of cats over 10 years of age
Clinical signs include weight loss, increased appetite, hyperactivity, and vomiting
Untreated hyperthyroidism leads to heart disease, hypertension, and kidney failure
Radioiodine (I-131) therapy is curative in over 95% of cases with a single treatment
Cats require isolation for 1-3 weeks post-treatment due to radioactivity

Welfare Considerations

Feline hyperthyroidism causes chronic physiological stress through elevated thyroid hormone levels, leading to weight loss despite increased appetite, muscle wasting, and cardiovascular complications. The disease significantly reduces quality of life. Radioiodine treatment offers permanent cure without the stress of daily medication, though the required isolation period can itself cause distress in social cats. Providing environmental enrichment during isolation and reuniting cats with their owners as soon as safely possible improves welfare during this period.

What You Can Do

Have cats over 10 years checked annually for hyperthyroidism with blood tests
Discuss radioiodine therapy with your vet as a curative option if your cat is diagnosed
Provide enrichment and familiar scent items during any necessary isolation period
Monitor kidney function carefully after treatment as hyperthyroidism can mask kidney disease
Follow post-treatment monitoring protocols to detect recurrence early